BMI, disease duration among predictors of NAFLD in Crohn's patients in China - Healio

4/15/2022 12:00:00 AM3 yearsago

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn’s disease, according to research published in BMC Gastroenterology.

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn’s disease, according to research published in B… [+1907 chars]

full article...

BMI, disease duration among predictors of NAFLD in Crohn's patients in China - Healio

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn&rsquo;s disease, according to research published in BMC Gastroenterology.

BMI, serum transaminase, pre-albumin levels and disease duration may predict the development of nonalcoholic fatty liver disease in patients with Crohn’s disease, according to research published in BMC Gastroenterology.